Edición internacional

SPECIFICATION OF DRUG SUBSTANCES AND PRODUCTS: DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS (HB 2014)

RILEY C.M.

ISBN 10: 0080983502 ISBN 13: 9780080983509
Editorial: ELSEVIER, 2014
Usado Encuadernación de tapa dura

Librería: UK BOOKS STORE, London, LONDO, Reino Unido Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Vendedor de AbeBooks desde 11 de marzo de 2024

Este artículo en concreto ya no está disponible.

Descripción

Descripción:

Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. N° de ref. del artículo cbs 9780080983509

Denunciar este artículo

Sinopsis:

Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This book is intended as more than a review of new regional guidelines, existing regulatory guidance, and industry practices. It provides a hands-on guide to understanding and applying these in practice. The authors discuss critical issues, novel approaches, and future directions while also providing insight into how International Guidelines were developed and the rationale behind them.

Acerca de los autores:

Dr. Christopher Riley is the President of Riley and Rabel Consulting Services. He received a bachelor’s degree in Pharmacy (1977) and PhD degree in Pharmaceutical Chemistry (1980) from the University of Bath, UK. He taught Pharmaceutical Chemistry, at the Universities of Florida (1983-6) and the University of Kansas (1986-94), and was a Vice President at DuPont Merck (1994-2001) and ALZA (a division of J&J) (2001-7). He has coauthored more than 140 book chapters and papers in peer-reviewed journals, as well as 5 books. He has extensive experience in CMC regulatory affairs and the development of all types of dosage forms.



Former Director of Business Development at Acceleration Laboratory Services, Incorporated. He has previously held scientific and senior management positions at The Upjohn Company, Marion Laboratories, Marion Merrell Dow, Hoechst Marion Roussel, Quintiles, Eli Lilly, Beckloff Associates, and PPD. He currently serves on a Small Molecule USP Expert Committee.

"Sobre este título" puede pertenecer a otra edición de este libro.

Detalles bibliográficos

Título: SPECIFICATION OF DRUG SUBSTANCES AND ...
Editorial: ELSEVIER
Año de publicación: 2014
Encuadernación: Encuadernación de tapa dura
Condición: New Books
Edición: Edición Internacional

Los mejores resultados en AbeBooks